Overview of the Global Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In 2021, the global market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -7.1% to $X for the first time since 2017, thus ending a three-year rising trend. Overall, consumption, however, continues to indicate resilient growth. Global consumption peaked at $X in 2020, and then reduced in the following year.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production declined to $X in 2021 estimated in export price. Over the period under review, production, however, recorded a strong increase. The most prominent rate of growth was recorded in 2020 when the production volume increased by 28%. As a result, production reached the peak level of $X, and then fell in the following year.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports

In 2021, after four years of growth, there was decline in overseas shipments of hormones, prostaglandins, thromboxanes and leukotrienes, when their volume decreased by -3.7% to X tons. Overall, total exports indicated a resilient increase from 2012 to 2021: its volume increased at an average annual rate of +5.3% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +63.6% against 2016 indices. The most prominent rate of growth was recorded in 2020 when exports increased by 22% against the previous year. As a result, the exports reached the peak of X tons, and then declined modestly in the following year.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports expanded slightly to $X in 2021. Over the period under review, total exports indicated a moderate expansion from 2012 to 2021: its value increased at an average annual rate of +3.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +59.2% against 2016 indices. The most prominent rate of growth was recorded in 2019 when exports increased by 19% against the previous year. Over the period under review, the global exports hit record highs in 2021 and are likely to see gradual growth in the immediate term.

Exports by Country

China (X tons) and Ireland (X tons) represented roughly 59% of total exports in 2021. It was distantly followed by Argentina (X tons) and the United States (X tons), together achieving a 12% share of total exports. Denmark (X tons), Italy (X tons), Spain (X tons), India (X tons), Belgium (X tons), France (X tons), Mexico (X tons) and Germany (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Argentina (with a CAGR of +33.0%), while shipments for the other global leaders experienced more modest paces of growth.

In value terms, Ireland ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier worldwide, comprising 29% of global exports. The second position in the ranking was taken by the United States ($X), with a 10% share of global exports. It was followed by Denmark, with an 8.6% share.

From 2012 to 2021, the average annual growth rate of value in Ireland totaled +16.7%. The remaining exporting countries recorded the following average annual rates of exports growth: the United States (-3.0% per year) and Denmark (+14.6% per year).

Export Prices by Country

In 2021, the average export price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, picking up by 7.5% against the previous year. In general, the export price, however, recorded a mild setback. The pace of growth appeared the most rapid in 2019 when the average export price increased by 14% against the previous year. Over the period under review, the average export prices attained the maximum at $X per kg in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Belgium ($X per kg), while China ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by India (+15.4%), while the other global leaders experienced more modest paces of growth.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports

In 2021, purchases abroad of hormones, prostaglandins, thromboxanes and leukotrienes decreased by -6.8% to X tons, falling for the second year in a row after two years of growth. The total import volume increased at an average annual rate of +1.5% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2013 when imports increased by 16%. Global imports peaked at X tons in 2015; however, from 2016 to 2021, imports stood at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports rose significantly to $X in 2021. The total import value increased at an average annual rate of +3.6% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2019 when imports increased by 20%. Over the period under review, global imports hit record highs in 2021 and are likely to see steady growth in the immediate term.

Imports by Country

India (X tons) and the United States (X tons) represented the largest importers of hormones, prostaglandins, thromboxanes and leukotrienes in 2021, finishing at approx. 14% and 14% of total imports, respectively. Italy (X tons) held the next position in the ranking, followed by Canada (X tons), Belgium (X tons) and Spain (X tons). All these countries together took near 27% share of total imports. France (X tons), the UK (X tons), Pakistan (X tons), Germany (X tons), Brazil (X tons), Mexico (X tons) and Iran (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Iran (with a CAGR of +14.0%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($X) constitutes the largest market for imported hormones, prostaglandins, thromboxanes and leukotrienes worldwide, comprising 28% of global imports. The second position in the ranking was taken by Belgium ($X), with an 11% share of global imports. It was followed by Italy, with a 10% share.

From 2012 to 2021, the average annual growth rate of value in the United States stood at +18.1%. In the other countries, the average annual rates were as follows: Belgium (-0.1% per year) and Italy (+5.9% per year).

Import Prices by Country

The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, with an increase of 17% against the previous year. Over the period under review, import price indicated a noticeable increase from 2012 to 2021: its price increased at an average annual rate of +2.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, hormones, prostaglandins, thromboxanes and leukotrienes import price increased by +25.2% against 2017 indices. The pace of growth appeared the most rapid in 2017 when the average import price increased by 24%. Over the period under review, average import prices hit record highs in 2021 and is expected to retain growth in the near future.

Prices varied noticeably country of destination: the country with the highest price was the United States ($X per kg), while Pakistan ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (+14.9%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :